In conclusion, we suggest that eRF3b/GSPT2, which differentially expressed in CHB and LC/HCC and influence the phosphorylation status of 4E-BP1, might be an important biomarker for HCC. This evidence concerns the gene GSPT2 and hepatocellular carcinoma.